Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer Moonshot^SM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Notice of Funding Opportunities

Title	Announcement Number	Activity Code	Clinical Trials Status Sort descending	Expiration Date	Program Official
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research	PAR-21-330 (U01 Clinical Trial Not Allowed)	U01	Clinical Trial Not Allowed	10/12/2024	Claire Zhu, Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers	PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed)	R00, K99	Clinical Trial Not Allowed	10/15/2026	Jessica Faupel-Badger, Ph.D., M.P.H.
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)	NOT-NS-20-107		Clinical Trial Not Allowed	05/16/2024	Brennan Streck, Ph.D., R.N., M.P.H.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-009 (R33 Clinical Trial Not Allowed)	R33	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-008 (R61 Clinical Trial Not Allowed)	R61	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)	NOT-OD-22-202		Clinical Trial Not Allowed	04/16/2025	Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Consortium for Palliative Care Research Across the Lifespan	RFA-AG-25-002 (U54 Clinical Trial Optional)	U54	Clinical Trial Optional	07/03/2024	Brennan Streck, Ph.D., R.N., M.P.H.
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research	PAR-24-153 (K12 Clinical Trial Optional)	K12	Clinical Trial Optional	02/19/2027	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research	PAR-22-099 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	05/08/2025	Richard Mazurchuk, Ph.D.
NCI Clinical and Translational Exploratory/Developmental Studies	PAR-22-216 (R21 Clinical Trial Optional)	R21	Clinical Trial Optional	07/02/2025	Marjorie Perloff, M.D.